MKI67 and neoplasm: The expression of KRAS and Ki67 in tumors treated with miRNA agomir was weaker than that in tumor treated with the NC, indicating that KRAS expression might be decreased by miR-30b-5p or miR-30e-5p (Figures 6H, I).